Bahareh Honarparvar

According to our database, Bahareh Honarparvar authored at least 4 papers between 2013 and 2019.

Collaborative distances:

• Dijkstra number of six.
• Erdős number of six.

2019

Estrogenic Active Stilbene Derivatives as Anti-Cancer Agents: A DFT and QSAR Study.

Bilal Nizami, Elham Mousavinezhad Sarasia, Mehbub I. K. Momin, Bahareh Honarparvar

IEEE ACM Trans. Comput. Biol. Bioinform., 2019

2018

An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant.

Zainab K. Sanusi, Thavendran Govender, Glenn E. M. Maguire, Sibusiso B. Maseko, Johnson Lin, Hendrik G. Kruger, Bahareh Honarparvar

J. Comput. Aided Mol. Des., 2018

Molecular insight on the non-covalent interactions between carbapenems and l, d-transpeptidase 2 from Mycobacterium tuberculosis: ONIOM study.

Thandokuhle Ntombela, Zeynab Fakhar, Collins U. Ibeji, Thavendran Govender, Glenn E. M. Maguire, Gyanu Lamichhane, Hendrik G. Kruger, Bahareh Honarparvar

J. Comput. Aided Mol. Des., 2018

2013

Molecular modelling studies of synthesized pentacyclo-undecane peptides as potential HIV-1 wild type C-SA protease inhibitors.

Bahareh Honarparvar, Hendrik G. Kruger, Mahmoud E. S. Soliman, Glenn E. M. Maguire, Thavendran Govender

J. Cheminformatics, 2013